Jenny Stjernberg

PhD, Director, Commercial Operations EMEA • ScaleReady

Jenny Stjernberg leads Commercial Operations as EMEA Director for ScaleReady as part of the Global Leadership Team, and is based in Europe. In her role she collaborates closely with the US Commercial Team and together, they set the tone globally enabling ScaleReady to challenge the way cell and gene therapy programs operate to adopt a simpler and consistent solution that centres around platform, process, and therefore, product continuity. 

Prior to ScaleReady, Jenny spent 5 years successfully managing large sales and marketing teams within several cell and gene therapy companies. This, combined with her first-hand experience as a scientist and as a clinical account manager has enabled her to gain a unique global perspective that spans the needs for academic research process development and commercial manufacturing operations. 

Jenny’s career-long background in science began by obtaining her Master’s Degree in Medical Biology from Linköping University in Sweden, alongside achieving a Ph.D. in Medical Science, studying how cell-cell interactions in the bone marrow supports the haematopoietic progenitors in their lineage decision. 

Also speaking

Anji Miller

Skills Lead, Innovation Hubs for Gene Therapies, Senior Business Manager, • LifeArc

Paolo Morgese

Head of Public Affairs, Europe • Alliance for Regenerative Medicine

Tomer Bronshtein

Vice President, Business Development • Bonus Biogroup

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.